Literature DB >> 29248993

Challenges, Dilemmas and Factors Involved in PGD Decision-Making: Providers' and Patients' Views, Experiences and Decisions.

Robert Klitzman1.   

Abstract

Providers and patients are considering and pursuing PGD for ever-more conditions, but questions arise concerning how they make, view and experience these decisions, and what challenges they may face. Thirty-seven in-depth semi-structured interviews were conducted (with 27 IVF providers and 10 patients). Patients and providers struggled with challenges and dilemmas about whether to pursue PGD in specific cases, and how to decide. Respondents varied in how they viewed, experienced and made these choices, and for which conditions to pursue PGD (from lethal, childhood-onset conditions to milder, treatable, or adult-onset disorders). Several factors were involved, including differences in gene penetrance, predictability, and phenotypic expression, and disease severity, age of onset, treatability, stigma and degree of disability. Providers and patients face questions regarding possibilities of screening for more than one condition in one set of embryos, and limitations of PGD (e.g., inaccurate results). Characteristics of providers (e.g., amount of PGD experience, understandings of genetics, and use of genetic counselors), and of patients (e.g., related to broader moral and social attitudes) can also affect these decisions. These data, the first to examine several key questions concerning PGD, suggest that providers and patients confront several dilemmas. These findings have critical implications for future practice, guidelines, education and research.

Entities:  

Keywords:  Decision-making; Embryos; Ethics; Genetic testing; PGD

Mesh:

Year:  2017        PMID: 29248993     DOI: 10.1007/s10897-017-0173-9

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  36 in total

Review 1.  Risk communication in genetic testing for cancer susceptibility.

Authors:  R T Croyle; C Lerman
Journal:  J Natl Cancer Inst Monogr       Date:  1999

2.  Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer.

Authors:  I A P Derks-Smeets; J J G Gietel-Habets; A Tibben; V C G Tjan-Heijnen; M Meijer-Hoogeveen; J P M Geraedts; R van Golde; E Gomez-Garcia; E van den Bogaart; M van Hooijdonk; C E M de Die-Smulders; L A D M van Osch
Journal:  Hum Reprod       Date:  2014-03-06       Impact factor: 6.918

3.  Use of genetic tests among neurologists and psychiatrists: knowledge, attitudes, behaviors, and needs for training.

Authors:  Melissa Salm; Kristopher Abbate; Paul Appelbaum; Ruth Ottman; Wendy Chung; Karen Marder; Cheng-Shiun Leu; Roy Alcalay; Jill Goldman; Alexander Malik Curtis; Christopher Leech; Katherine Johansen Taber; Robert Klitzman
Journal:  J Genet Couns       Date:  2013-06-21       Impact factor: 2.537

4.  Reducing the number of fetuses in a pregnancy: providers' and patients' views of challenges.

Authors:  Robert L Klitzman
Journal:  Hum Reprod       Date:  2016-10-06       Impact factor: 6.918

5.  Preimplantation genetic diagnosis: patients' experiences and attitudes.

Authors:  S A Lavery; R Aurell; C Turner; C Castello; A Veiga; P N Barri; R M Winston
Journal:  Hum Reprod       Date:  2002-09       Impact factor: 6.918

6.  Attitudes of high-risk women toward preimplantation genetic diagnosis.

Authors:  Gwendolyn Quinn; Susan Vadaparampil; Crystal Wilson; Lindsey King; Jimin Choi; Cheryl Miree; Sue Friedman
Journal:  Fertil Steril       Date:  2008-04-28       Impact factor: 7.329

7.  Reproductive Endocrinologists' Utilization of Genetic Counselors for Oncofertility and Preimplantation Genetic Diagnosis (PGD) Treatment of BRCA1/2 Mutation Carriers.

Authors:  Allison L Goetsch; Catherine Wicklund; Marla L Clayman; Teresa K Woodruff
Journal:  J Genet Couns       Date:  2015-11-14       Impact factor: 2.537

8.  Genetic testing of embryos: practices and perspectives of US in vitro fertilization clinics.

Authors:  Susannah Baruch; David Kaufman; Kathy L Hudson
Journal:  Fertil Steril       Date:  2007-07-12       Impact factor: 7.329

9.  Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer.

Authors:  U Menon; J Harper; A Sharma; L Fraser; M Burnell; K ElMasry; C Rodeck; I Jacobs
Journal:  Hum Reprod       Date:  2007-04-11       Impact factor: 6.918

10.  How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization.

Authors:  Robert L Klitzman
Journal:  Fertil Steril       Date:  2016-04-02       Impact factor: 7.329

View more
  6 in total

Review 1.  A systematic review of the views of healthcare professionals on the scope of preimplantation genetic testing.

Authors:  Maria Siermann; Zoë Claesen; Laurent Pasquier; Taneli Raivio; Olga Tšuiko; Joris Robert Vermeesch; Pascal Borry
Journal:  J Community Genet       Date:  2022-01-14

2.  The decision-making process, experience, and perceptions of preimplantation genetic testing (PGT) users.

Authors:  Shachar Zuckerman; Sigal Gooldin; David A Zeevi; Gheona Altarescu
Journal:  J Assist Reprod Genet       Date:  2020-05-27       Impact factor: 3.412

3.  Impediments to communication and relationships between infertility care providers and patients.

Authors:  Robert Klitzman
Journal:  BMC Womens Health       Date:  2018-06-05       Impact factor: 2.809

4.  Patients' preimplantation genetic testing decision-making experience: an opinion on related psychological frameworks.

Authors:  L M Pastore; C N Cordeiro Mitchell; L R Rubin; J Nicoloro-SantaBarbara; M C Genoff Garzon; M Lobel
Journal:  Hum Reprod Open       Date:  2019-10-04

5.  Attitudes toward preimplantation genetic testing and quality of life among individuals with hereditary diffuse gastric cancer syndrome.

Authors:  Ibrahim H Shah; Erin E Salo-Mullen; Kimberly A Amoroso; David Kelsen; Zsofia K Stadler; Jada G Hamilton
Journal:  Hered Cancer Clin Pract       Date:  2022-09-02       Impact factor: 2.164

6.  Predictive Prenatal Diagnosis for Infantile-onset Inflammatory Bowel Disease Because of Interleukin-10 Signalling Defects.

Authors:  Ziqing Ye; Wenhui Hu; Bingbing Wu; Yueping Zhang; Caixia Lei; Isabelle Williams; Dror S Shouval; Hirokazu Kanegane; Kyung Mo Kim; Lissy de Ridder; Neil Shah; Galina Ling; Baruch Yerushalmi; Daniel Kotlarz; Scott Snapper; Ruth Horn; Christoph Klein; Aleixo M Muise; Ying Huang; Holm H Uhlig
Journal:  J Pediatr Gastroenterol Nutr       Date:  2021-02-01       Impact factor: 3.288

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.